<SEC-DOCUMENT>0000943440-12-001073.txt : 20121024
<SEC-HEADER>0000943440-12-001073.hdr.sgml : 20121024
<ACCEPTANCE-DATETIME>20121024134545
ACCESSION NUMBER:		0000943440-12-001073
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20121022
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20121024
DATE AS OF CHANGE:		20121024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0330

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		121158112

	BUSINESS ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
		BUSINESS PHONE:		9549794788

	MAIL ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>petmed_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Current Report</TITLE>
<META NAME="author" CONTENT="BR">
<META NAME="date" CONTENT="10/19/2011">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<A NAME="eolPage1"></A><P style="margin:0px">&nbsp;<A NAME="FIS_TOP_OF_DOCUMENT"></A>&nbsp;<A NAME="B416715_8K_HTM"></A>&nbsp;<A NAME="FIS_FORM"></A>&nbsp;<A NAME="FIS_UNIDENTIFIED_TABLE"></A></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial; font-size:13.5pt" align=center><B>FORM 8-K</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center>Date of report (Date of earliest event reported): October 22, 2012</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=24.267 /><TD width=129.333 /><TD width=153.6 /><TD width=153.6 /><TD width=153.6 /><TD width=153.6 /></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=743.733 colspan=5><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>PetMed Express, Inc.<BR>
</U></B> (Exact name of registrant as specified in its charter)</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6 colspan=2><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6 colspan=2><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>Florida</U></B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>000-28827</U></B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>65-0680967</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6 colspan=2><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(State or other jurisdiction<BR>
of incorporation)</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(Commission<BR>
File Number)</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(I.R.S. Employer<BR>
Identification No.)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=768 /></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center><B><U>1441 S.W. 29</U></B><B><U><SUP>th</SUP></U></B><B><U> Avenue, &nbsp;Pompano Beach, FL &nbsp;33069</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center>(Address of principal executive offices) (Zip Code)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=751.4 /><TD width=16.6 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=751.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center><B><U>(954) 979-5995</U></B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=16.6><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=751.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center>(Registrant&#146;s telephone number, including area code)</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=16.6><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=768 /></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center><B><U>Not Applicable</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center>(Former name or former address, if changed since last report)</P>
</TD></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=24.267 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD><A NAME="eolPage2"></A><A NAME="FIS_OTHER_EVENTS"></A></TR>
</TABLE>
<P style="line-height:11.25pt; margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="line-height:11.25pt; margin:0px; page-break-before:always"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=24.267 /><TD /></TR>
</TABLE>
<P style="line-height:0.05pt; margin:0px"><BR></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman"><B>Item 8.01&nbsp;&nbsp;&nbsp;Other Events.</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:24px; font-family:Arial,Times New Roman" align=justify>On October 22, 2012, PetMed Express, Inc. discussed its financial results for the quarter ended September 30, 2012. &nbsp;A copy of this conference call transcript is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman"><B>Item 9.01&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=77.733 /><TD width=24.2 /><TD width=666.067 /></TR>
<TR><TD style="margin-top:0px" valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">(d)</P>
</TD><TD style="margin-top:0px" valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Exhibits.</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">99.1 &#150; Conference call transcript by PetMed Express, Inc. on October 22 2012.</P>
</TD><A NAME="FIS_EXHIBIT_INDEX"></A></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman" align=center><B>EXHIBIT INDEX</B></P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=80.8 /><TD width=17.133 /><TD width=652.933 /><TD width=17.133 /></TR>
<TR><TD style="margin-top:0px" valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman"><U>Exhibit No.</U></P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman"><U>Description</U></P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">99.1</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Conference call transcript by PetMed Express, Inc. on October 22 2012.</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><A NAME="FIS_SIGNATURES"></A></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman" align=center><B>SIGNATURES</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman">Dated: October 24, 2012</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD /><TD width=46.4 /><TD width=338.2 /></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=384.6 colspan=2><P style="margin:0px; padding-right:2.4px; font-family:Arial,Times New Roman">PETMED EXPRESS, INC.</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">By:</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman"><U>/s/ Bruce S. Rosenbloom</U></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Name:</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Bruce S. Rosenbloom</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Title:</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Chief Financial Officer</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin-top:12.533px; margin-bottom:0px; font-family:Arial,Times New Roman" align=center>2</P>
<P style="margin-top:12.533px; margin-bottom:0px" align=center><BR>
<BR></P>
</BODY>
<!-- EDGAR Validation Code: CAD3A424 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>petmed_ex99z1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Press Release</TITLE>
<META NAME="author" CONTENT="Shane Mirkovich">
<META NAME="date" CONTENT="07/25/2012">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=right><B>EXHIBIT 99.1</B></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>PETMED EXPRESS, INC.</B></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>QUARTER ENDED SEPTEMBER 30, 2012</B></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>CONFERENCE CALL TRANSCRIPT</B></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>OCTOBER 22, 2012 AT 8:30 A.M. ET</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Welcome to the PetMed Express Incorporated doing business as 1-800 PetMeds Conference Call to review the financial results for the second fiscal quarter and six months ended on September 30, 2012. At the request of the company, this conference call is being recorded. &nbsp;Founded in 1996, 1-800-PetMeds is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats direct to the consumer. &nbsp;1-800-PetMeds markets its products through national television, online, direct mail and print advertising campaigns which direct consumers to order by phone or on the internet and aim to increase the recognition of the PetMeds family of brand names. &nbsp;1-800-PetMeds provides an attractive alternative for updating pet medications in terms of convenience, price, ease of ordering and rapid home delivery. &nbsp;At this time I would like to turn the call over to the company's Chief Financial Officer, Mr. Bruce Rosenbloom and sir you may begin.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Bruce Rosenbloom:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. I'd like to welcome everybody here today. &nbsp;Before I turn the call over to Mendo Akdag, our President and Chief Executive Officer, I would like to remind everyone that the first portion of this conference call will be listen only until the question and answer session which will be later in the call. &nbsp;Also, certain information that will be included in this press conference may include forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or the Securities and Exchange Commission that may involve a number of risks and uncertainties. &nbsp;These statements are based on our beliefs as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risk, uncertainties and assumptions. Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by these statements. &nbsp;We have identified various risk factors associated with our operations in our most recent annual report and other filings with the Securities and Exchange Commission. &nbsp;Now let me introduce today's speaker, Mendo Akdag, the President and Chief Executive Officer of 1-800-PetMeds, Mendo.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you Bruce. Welcome everybody, thank you for joining us. Today we will review the highlights of our financial results. We'll compare our second fiscal quarter and six months ended on September 30, 2012 to last year's quarter and six months ended on September 30, 2011. &nbsp;For the second fiscal quarter ended on September 30, 2012 sales were relatively flat at $58.1 million compared to sales of $58.2 for the same period the prior year. &nbsp;For the six months ended on September 30, 2012 sales were $127.1 million compared to $131.8 million for the six months the prior year -- a decrease of 3.6%. &nbsp;The sales stabilized for the quarter even though the average order value was about 5% lower at $72 compared to $76 for the same quarter the prior year. The decrease in average order value was due to additional discounts given and a change in product mix to lower priced items, mainly generics. &nbsp;Also the unavailability of the Novartis Brands continued to negatively impact our sales.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>For the second fiscal quarter net income was $4.0 million or $0.20 diluted per share compared to $3.9 million or $0.19 diluted per share for the same quarter the prior year, an increase to earnings per share of 6%. &nbsp;For the six months net income was $8.0 million or $0.40 diluted per share compared to $8.8 million or $0.41 diluted per share a year ago, a decrease to earnings per share of 4%. &nbsp;The increase for the quarter was due to a decrease in operating expenses and the decrease for the six months was mainly due to lower sales in the June quarter.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>Reorder sales increased by 2.1% to $46.4 million for the quarter compared to reorder sales of $45.5 million for the same quarter the prior year. For the six months the reorder sales slightly decreased to $101.5 million compared to $102.1 million for the same period last year. &nbsp;New order sales decreased by 8.1% to $11.7 million for the quarter compared to $12.7 million for the same period last year. For the six months the new order sales decreased by 13.8% to $25.6 million compared to $29.7 million for the same period last year. &nbsp;The decreases were mainly due to reduction in advertising and decreases in average order value.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 1 of 5</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px" align=justify><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>We acquired approximately 177,000 new customers in our second fiscal quarter compared to 184,000 for the same period the prior year. And we acquired approximately 374,000 new customers in the six months compared to 410,000 for the same period a year ago. &nbsp;Approximately 77% of our sales were generated on our website for the quarter compared to 74% for the same period the prior year which resulted in a 2.9% increase to our online sales for the quarter compared to the same quarter last year. &nbsp;The seasonality in our business is due to the proportion of flea, tick and heartworm medications in our product mix, spring and summer are considered peak seasons, with fall and winter being the off seasons.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>For the second fiscal quarter our gross profit as a percent of sales was 33.3% compared to 34.2% for the same period the prior year, and for the six months our gross profit as a percent of sales was 32.8% compared to 33.4% for the same period a year ago. &nbsp;The percentage decreases can be attributed to increases in freight costs to improve service levels.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>Our general and administrative expenses as a percent of sales improved to 9.2% for the quarter compared to 9.6% for the same period a year ago, and for the six months it was 8.9% which was the same as the six months the prior year.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>For the quarter we spent $7.4 million in advertising compared to $7.9 million for the same quarter the prior year. The reduction of advertising for the quarter was due to the unavailability of TV remnant space inventory. &nbsp;For the six months we spent $17.3 million in advertising compared to $18.0 million during the same period a year ago. The advertising cost of acquiring a customer improved to $42 for the quarter compared to $43 for the same quarter the prior year. For the six months it was $46 compared to $44 for the same period a year ago.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>We had $47.0 million in cash and cash equivalents, $15.4 million in short-term investments and $19.6 million in inventory with no debt as of September 30, 2012. Net cash from operations for the six months was $15.7 million. Capital expenditures for the six months were approximately $290,000. &nbsp;In accordance with our share repurchase program we repurchased approximately 397,000 shares, paying approximately $3.9 million during the quarter at an average price of $9.74.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>This ends the financial review. Operator we are ready to take questions.</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. At this time if you'd like to ask a question please press star 1 on your touchtone phone. Please unmute your phone and record your name clearly when prompted. One moment please. &nbsp;And we do have a question coming in from Kevin Ellich, Piper Jaffray, your line is open.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Good morning guys. Just a couple questions, I guess first of all...</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Good morning.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Mendo, good morning. You mentioned the unavailability of TV advertising remnant space this quarter, are you still seeing that impact or have things started to open up?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We're still seeing the impact and we expect to see it until November 6th.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Until after - so it's really due to the election. So is it safe to assume that we should be looking at advertising expenditures, you know, being lower on a year-to-year basis similar to what we saw this quarter?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Probably, yes.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay. And then you also mentioned the discounts that impacted this quarter. Are you still offering any discount programs?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Yes we are. But it's - right now it's similar to what we did last year.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 2 of 5</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px" align=justify><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Got it, got it, and then do you have any update or thought on when Novartis might be back online? We heard maybe by the end of the year but it seems to be - it seems like there's some conflicting information out there.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>The latest information we have is the beginning of 2013.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Beginning of 2013, okay, got it. And then last question here -- it looks like, you know, Bruce maybe, on the cash flow statement we saw some investments -- just wondering if there's anything you can talk about on that front?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Bruce Rosenbloom:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We did invest additional cash into some short-term investments. We've held those short-term investments for a few years now and we just upped our balance from about $10.0 million to about $15.0 million.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Got it, okay. And then can you give - remind us where the buyback authorization is? Is it around $10 million now?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>About $10 million remaining, yes.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Kevin Ellich:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, got it. Thanks guys.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You're welcome.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. Next question comes from Erin Wilson, Bank of America/Merrill Lynch, your line is open.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Can you give us an update on the supplies and accessories business and how that's progressing?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>It's increasing but we're not going to get into the specifics.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay. And then I guess I understand it's been inherently lower margin business but, I mean, are there ways to improve the profitability for that segment and are you still considering switching from your third party fulfillment strategy?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We are still using a third party fulfillment. As far as profitability is concerned, that depends on the product mix and we will only really carry it if it adds value and loyalty to our customer base - increase loyalty I should say.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and then I'm curious what your thoughts were on the FTC discussion a few weeks ago. Did you expect - or do you expect, I guess, a follow-up to that with some sort of broader investigation or legislation?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We are not going to speculate on what FTC may or may not do. If and when they take any action we can talk about it.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay. Thanks.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. Next question comes from Michael Kupinski, Noble Financial, your line is open.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Michael Kupinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thanks for taking the question. On the pet accessories are you still planning on carrying an inventory of pet accessories at this point? And I just wanted to follow-up on that one question there.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We are currently using third party fulfillment if that changes we'll let you know.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Michael Kupinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay. And did you notice any difference in the competitive landscape in the quarter for - particularly for flea and tick?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>No, it was similar to last year.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 3 of 5</P>
<P style="line-height:11pt; margin:0px" align=justify><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Michael Kupinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and then what - could you identify the revenue impact from the Novartis plant closings in the quarter -- what would you say was the revenue impact?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Our rough estimate is about $2 million.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Michael Kupinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and then just some housekeeping items -- the depreciation and amortization was a little lower -- is that a good run rate going forward or was there any particular reason for that to be down in the quarter -- from my estimate at least.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Right, there's been a reduction in capital expenditures and that's the reason it has been down. It depends on if we make any major capital expenditures, spending. At this time we are not planning on it but if we do we'll let you know.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Michael Kupinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>If you can just remind me -- if the prospect for capital expenditures is that for updating the warehouse that you have in Pompano or what would be the reason why you would have an increase in CAPEX?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>The distribution center is one possibility -- the other possibility change in our systems and software.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Michael Kupinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, all right. Thank you. That's all I have.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You're welcome.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. Next question comes from Anthony Lebiedzinski with Sidotti and Company your line is open.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Good morning, a couple of questions - so, first, are you still seeing more customers ordering three packs versus six packs, for example, of flea and tick products? I know you mentioned this on your previous calls.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>It was in the September quarter it was similar to the same quarter last year.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and your G&amp;A costs were down a little bit more so than what we had expected. Is there anything - I know there is some seasonality in the expenses -- just wondering if perhaps you cut back on certain incentives, compensation expenses or anything else that we should think about?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>It was credit card processing fees, professional fees, and a slight decrease in payroll, were the three that caused the reduction.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, all right, thank you very much.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You're welcome.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you, and once again if you would like to ask a question please press star 1 on your touchtone phone -- and our next question comes from Mitch Bartlett, Craig-Hallum Company, your line is open, you may ask your question.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mitchell Bartlett:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. I was just wondering if you could characterize kind of the pharmacy and the non-prescription side of the business. What is the trend on those two sides of the business broadly?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Actually in the September quarter the OTC was up and RX went down slightly, but the main reason is the unavailability of the Novartis brands.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mitchell Bartlett:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>The strength of the OTC how do you - is that new creative? What are you doing to see that kind of response after a couple years where it's been a little rocky?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Generics and being more aggressive, offering more discounts.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mitchell Bartlett:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>And the generics, what do you think that contributed to the decline in the AOV? How does that look?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 4 of 5</P>
<P style="line-height:11pt; margin:0px" align=justify><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We're not going to comment on that.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mitchell Bartlett:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, thank you.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You're welcome.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>And our next question comes from Ross Taylor, CL King. Your line is open you may ask your question.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Ross Taylor:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Yes, my first question just has to do with, you know, some of your generic offerings or your initiatives on that side. I mean, has the generic products and particularly the Flea4X -- they, you know, progressed as you expected, you know, as a percent of your sales mix?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Yes, we're cautiously optimistic with it, but other than that we're not going to get into any specific data points.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Ross Taylor:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and my second question -- you know, your customer acquisition costs were, you know, down a little bit, year over year, and certainly down a lot from what you had in the June quarter. If you are able, you know, to significantly increase your TV advertising once you get past the election, is that likely to boost your, you know, customer acquisition costs materially or how much you manage that?</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We were more efficient in the September quarter compared to the June quarter. In the June quarter we forced it and that's never a good idea. And we stuck to the fundamentals in the September quarter and took what was there, and we intend to continue to do that.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Ross Taylor:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and my final question is, you know, just trying to get a sense of the, you know, how the mild winter maybe has affected the flea and tick business, you know, over the first nine months of this year. I just wondered if you, you know, had any sense if in the September quarter the mix of flea and tick sales if you adjust for Novartis was kind of where it might normally be and whether you just see any evidence that, you know, maybe a lot of business was pulled forward into the March quarter from June.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>That is correct. It was stronger, the flea business was stronger in the September quarter. And as you know the March quarter was strong and the June quarter was weak. Probably there was some revenue shift from June to March.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Ross Taylor:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, that's helpful. Thanks very much.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You're welcome.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>And now I'd like to turn the call back over to Mendo Akdag and sir you may begin.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. Going forward we are focusing on advertising efficiency and shifting sales to higher margin items while continuing to expand our product offerings. This wraps up today's conference call. Thank you for joining us. &nbsp;Operator this ends the conference call.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. That does conclude today's conference call you may disconnect at this time.</P>
<P style="line-height:11pt; margin:0px; clear:left" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; padding-left:144px; text-indent:-144px; font-family:Arial,Times New Roman" align=justify>END</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 5 of 5</P>
<P style="line-height:11pt; margin:0px" align=justify><BR></P>
<P style="line-height:11pt; margin:0px" align=center><BR></P>
<P style="line-height:11pt; margin:0px" align=center><BR>
<BR></P>
</BODY>
<!-- EDGAR Validation Code: 6856A657 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
